Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection

por Ahmed, Ossama A, Elsebaey, Mohamed A, Fouad, Mohamed Hassan A, Elashry, Heba, Elshafie, Ahmed I, Elhadidy, Ahmed A, Esheba, Noha E, Elnaggar, Mohammed H, Soliman, Shaimaa, Abd-Elsalam, Sherief
Publicado 2018

Sofosbuvir Plus Daclatasvir in Treatment of Chronic Hepatitis C Genotype 4 Infection in a Cohort of Egyptian Patients: An Experiment the Size of Egyptian Village

por Ahmed, Ossama Ashraf, Safwat, Eslam, Khalifa, Mohamed Omar, Elshafie, Ahmed I., Fouad, Mohamed Hassan Ahmed, Salama, Mohamed Magdy, Naguib, Gina Gamal, Eltabbakh, Mohamed Mahmoud, Sherief, Ahmed Fouad, Abd-Elsalam, Sherief
Publicado 2018